Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST6GAL1 | P15907 | 12/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sialic Acid SCHEMBL30081458 | 0.95 | ST6GAL1 (0.50) | ST6GAL1TSHRGLAP2RY2 | |
| Sialic Acid SCHEMBL2296552 | 0.95 | ST6GAL1 (0.50) | ST6GAL1TSHRGLAP2RY2 | |
| Sialic Acid SCHEMBL30081457 | 0.95 | ST6GAL1 (0.50) | ST6GAL1TSHRGLAP2RY2 | |
| Sialic Acid SCHEMBL21068057 | 0.95 | ST6GAL1 (0.50) | ST6GAL1TSHRGLAP2RY2 | |
| Sialic Acid SCHEMBL29668373 | 0.95 | ST6GAL1 (0.50) | ST6GAL1TSHRGLAP2RY2 | |
| SCHEMBL237564 | 0.90 | ST6GAL1 (0.45) | ST6GAL1TSHRGLA | |
| Sialic Acid SCHEMBL28452247 | 0.89 | ST6GAL1 (0.54) | ST6GAL1TSHRGLA | |
| Cytarabine 5'-Phosphate SCHEMBL26630601 | 0.89 | ST6GAL1 (0.47) | ST6GAL1TSHRGLAP2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL19423351 | 0.89 | ST6GAL1 (0.47) | ST6GAL1TSHRGLAP2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL15652697 | 0.88 | ST6GAL1 (0.47) | ST6GAL1TSHRGLAP2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | NEOSE TECHNOLOGIES, INC. (US) | 2008-12-25 | — | — | US | claimed |
| EP-1720892-A4 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | NEOSE TECHNOLOGIES INC (US) | 2007-07-25 | — | — | EP | claimed |
| EP-1720892-A2 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | Neose Technologies, Inc. (US) | 2006-11-15 | — | — | EP | claimed |
| WO-2005072371-A2 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | NEOSE TECHNOLOGIES, INC. (US) | 2005-08-11 | — | — | WO | claimed |
| EP-1720892-B1 | Branched polymer-modified sugars and nucleotides | BIOGENERIX AG (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | NEOSE TECHNOLOGIES, INC. (US) | 2008-12-25 | — | — | US | disclosed |
| EP-1720892-A4 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | NEOSE TECHNOLOGIES INC (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1720892-A2 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | Neose Technologies, Inc. (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005072371-A2 | BRANCHED POLYMERIC SUGARS AND NUCLEOTIDES THEREOF | NEOSE TECHNOLOGIES, INC. (US) | 2005-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | GALE, NUDT14, GNE | ST6GAL1 93/4885TSHR 4614/4885GLA 515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.